48 F. Atzeni et al.mimics of fibromyalgia. Curr Pain Head Rep 2006; 10:327-332.41. Klippel JH, Crofford LJ, Stone JH, Weyand CM, eds.Primer on the rheumatic diseases. Atlanta: ArthritisFoundation; 20<strong>01</strong>.42. Ostergaard M., Ejbjerg B, Szkudlarek M. Imaging inearly rheumatoid arthritis: roles of magnetic resonanceimaging, ultrasonography, conventional radiographyand computed tomography. Best Pract Res Clin Rheum -atol 2005; 19: 91-116.43. Joshua F, Lassere M, Bruyn GA, Szkudlarek M, NaredoE, Schmidt WA, et al. Summary findings of a systematicreview of the ultrasound assessment of synovitis.J Rheumatol 2007; 34: 839-47.44. Grassi W, Filippucci E. Ultrasonography and therheumatologist. Curr Opin Rheumatol 2007; 19: 55-60.45. Khan MA. Update on spondyloarthropathies. Ann InternMed 2002; 136: 896-907.46. Fitzcharles MA, Esdaile J. The overdiagnosis of fibromyalgiasyndrome. Am J Med 1997; 103: 44-50.47. Zochling J, Baraliakos X, Hermann KG, Braun J. Magneticresonance imaging in ankylosing spondylitis. CurrOpin Rheumatol 2007; 19: 346-52.48. Cervera R, Khamashta MA, Font J, Sebastiani GD, GilA, Lavilla P, et al. Morbidity and mortality in systemiclupus erythematosus during a 10-year period. Medicine2003; 82: 299-308.49. Fitzpatrick TB, Johnson RA, Wolff K, eds et al. ColorAtlas and Synopsis of Clinical Dermatology. NewYork: The McGraw-Hill Companies; 1997.50. Martinez-Lavin M. Overlap of Fibromyalgia with othermedical conditions. Curr Pain Head Rep 20<strong>01</strong>; 5:347-50.51. Martinez-Lavin M, Hermosillo AG. Autonomic nervoussystem dysfunction may explain the multi-systemfeatures of fibromyalgia. Semin Arthritis Rheum 2000;29: 197-9.52. Salaffi F, Carotti M, Argalia G, Salera D, GiuseppettiGM, Grassi W. Usefulness of ultrasonography and colorDoppler sonography in the diagnosis of major salivarygland diseases. Reumatismo 2006; 58: 138-56.53. Al-Allaf AW, Mole PA, Paterson CR, Pullar T. Bonehealth in patients with fibromyalgia. Rheumatology2003; 42: 1202-6.54. Briani C, Doria A, Sarzi-Puttini P, Dalakas MC. Updateon idiopatic inflammatory myopathies. Autoimmunity2006; 39: 161-70.55. Pamuk ON, Cakir N. The frequency of thyroid antibodiesin fibromyalgia patients and their relationshipwith symptoms. Clin Rheumatol 2007; 26: 55-9.56. Garrison RL, Breeding PC. A metabolic basis for fibromyalgiaand its related disorders: the possible role ofresistance to thyroid hormone. Med Hypotheses 2003;61: 182-9.57. Buskila D. Hepatitis C-associated arthritis. Curr OpinRheumatol 2000; 12: 295-9.58. Adak B, Tekeoglu I, Ediz L, Budancamanak M, YazganT, Karahocagil K, et al. Fibromyalgia frequency inhepatitis B carriers. J Clin Rheumatol 2005; 11: 157-9.59. Reilly PA. The differential diagnosis of generalizedpain. Baillieres Best Pract Res Clin Rheumatol 1999;13: 391-4<strong>01</strong>.60. Dreyer L, Mellemkjaer L, Kendall S, Jensen B,Danneskiold-Samsøe B, Bliddal H. Increased cancerrisk in patients referred to hospital with suspected fibromyalgia.J Rheumatol 2007; 34: 2<strong>01</strong>-6.61. Martinez-Lavin M. Biology and therapy of fibromyalgia.Stress, the stress response system, and fibromyalgia.Arthritis Res Ther 2007; 9: 216 (doi: 10.1186/ar2146).62. Furlan R, Colombo S, Perego F, Atzeni F, Diana A,Barbic F, et al. Abnormalities of cardiovascular neuralcontrol and reduced orthostatic tolerance in patientswith primary fibromyalgia. J Rheumatol. 2005; 32:1787-93.63. Sarzi-Puttini P, Rizzi M, Andreoli A, Panni B, Pecis M,Colombo S, et al. Hypersomnolence in fibromyalgiasyndrome. Clin Exp Rheumatol 2002; 20: 69-72.64. Rizzi M, Sarzi-Puttini P, Atzeni F, Capsoni F, AndreoliA, Pecis M, et al. Cyclic alternating pattern: a newmarker of sleep alteration in patients with fibromyalgia?J Rheumatol 2004; 31: 1193-9.65. Mountz JM, Bradley LA, Modell JG, Alexander RW,Triana-Alexander M, Aaron LA, et al. Fibromyalgia inwomen. Abnormalities of regional cerebral blood flowin the thalamus and the caudate nucleus are associatedwith low pain threshold levels. Arthritis Rheum 1995;38: 926-38.66. Kwiatek R, Barnden L, Tedman R, Jarrett R, Chew J,Rowe C, Pile K. Regional cerebral blood flow in fibromyalgia:single-photon-emission computed tomographyevidence of reduction in the pontine tegmentumand thalami. Arthritis Rheum. 2000; 43: 2823-33.67. Cohen-Gadol AA, Bradley CC, Williamson A, KimJH, Westerveld M, Duckrow RB, et al. Normal magneticresonance imaging and medial temporal lobeepilepsy: the clinical syndrome of paradoxical temporallobe epilepsy. J Neurosurg 2005; 103: 768-9.68. Iadarola MJ, Max MB, Berman KF, Byas-Smith MG,Coghill RC, Gracely RH, Bennett G. Unilateral decreasein thalamic activity observed with positron emissiontomography in patients with chronic neuropathicpain. Pain 1995; 63: 55-64.69. Di Piero V, Jones AK, Iannotti F, Powell M, Perani D,Lenzi GL, Frackowiak RS. Chronic pain: A PET studyof the central effects of percutaneous high cervical cordotomy.Pain 1991; 46: 9-12.70. Petzke F, Clauw DJ, Ambrose K, Khine A, GracelyRH. Increased pain sensitivity in fibromyalgia: effectsof stimulus type and mode of presentation. Pain 2003;105: 403-13.71. Grant MA, Farrell MJ, Kumar R, Clauw DJ, GracelyRH. fMRI evaluation of pain intensity coding in fibromyalgiapatients and controls. Arthritis Rheum20<strong>01</strong>; 44.72. Giesecke T, Gracely R H, Williams DA, Geisser M,Petzke F, Clauw DJ. The relationship between depression,clinical pain, and experimental pain in a chronicpain cohort. Arthritis Rheum 2005; 52: 1577-84.73. Burton AK, Tillotson KM, Main CJ, Hollis S. Psy-
The evaluation of the fibromyalgia patients 49chosocial predictors of outcome in acute and subchroniclow back trouble. Spine 1995; 20: 722-8.74. Gracely RH, Geisser <strong>ME</strong>, Giesecke T, Grant MA, PetzkeF, Williams DA, Clauw DJ. Pain catastrophizingand neural responses to pain among persons with fibromyalgia.Brain 2004; 127: 835-43.75. Kuchinad A Scweinhardt P Seminowicz DA Wood PBChizh BA Bushnell MC. Accelerated brain gray matterloss in fibromyalgia patients: premature. J Neurosci2007; 27: 4004-7.76. Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH,Zubieta JK. Decreased central mu-opioid receptor availabilityin fibromyalgia. J Neurosci 2007; 2: 10000-6.77. Mäntyselkä P, Kumpusalo E, Ahonen R, Kumpusalo A,Kauhanen J, Viinamäki H, et al. Pain as a reason to visitthe doctor; a study in Finnish primary health care.Pain 20<strong>01</strong>; 89: 175-80.78. Macfarlane GJ, Morris S, Hunt IM, Benjamin S, Mc-Beth J, Papageorgiou AC, et al. Chronic widespresdpain in the community: the influence of psychologicalsymptoms and mental disorder on healthcare seekingbehavior. J Rheumatol 1999; 26: 413-9.79. Salaffi F, Carotti M. Semeiotica e valutazione del doloremuscoloscheletrico. In “Clinimetria delle malattiemuscoloscheletriche. Scale e punteggi” Ed Mattioli1885; 19-58, 2007.80. Scott-Huskisson EC. Graphic Representation of pain.Pain 1976; 2: 175-84.81. Salaffi F, Stancati A, Silvestri CA, Ciapetti A, GrassiW. Minimal clinically important changes in chronicmusculoskeletal pain intensity measured on a numericalrating scale. Eur J Pain 2004; 8: 283-91.82. Melzack R. The McGill Pain questionnaire: major propertiesand scoring methods. Pain 1985; 1: 85-92.83. Salaffi F, Nolli M, Cavalieri F, Ferraccioli GF. Confrontotra indici algometrici nella valutazione dell'esperienzaalgica in Reumatologia. Utilità della versioneitaliana del questionario algologico McGill. Reumatismo1990; 42: 19-31.84. Sinclair D, Starz T, Turk D. The manual Tender PointSurvey. [Internet]. [Accessed July, 2005]. Availablefrom National Fibromyalgia Association: http://fmaware.org/doctor/tenderpt.htm85. Fordyce WE, Lansky D, Calsyn DA, Shelton JL, StolovWC, Rock DL. Pain measurement and pain behavior.Pain 1984; 18: 53-69.86. Scudds RA, Rollman GB, Harth M, McCain A. Pain perceptionand personality measures as discriminations in theclassification of fibrositis. J Rheumatol 1987; 14: 563-9.87. Belza BL, Henke CJ, Yelin EH, Epstein WV, GillisCL. Correlates of fatigue in older adults with rheumatoidarthritis. Nurs Res 1993; 42: 93-9.88. Webster K, Cella D, Yost K. The Functional Assessmentof Chronic Illness Therapy (FACIT) MeasurementSystem: properties, applications, and interpretation.Health Qual Life Outcomes 2003; 1: 79.89. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD.The Fatigue Severity Scale. Application to patients withmultiple sclerosi and systemic lupus erythematosus.Arch Neurol 1989; 46: 1121-3.90. Hays R, Stewart A. Measuring functioning and well-being.In: Stewart A, Ware J, editors. Durham, NC: DukeUniversity Press; 1992: 232-59.91. Franchignoni F, Salaffi F. Generic and specific measuresfor outcome assessment in orthopaedic and rheumatologicrehabilitation. In: Assessment in Physical Medicineand Rehabilitation - Advances in Rehabilitation. M.Barat, F. Franchignoni Eds. 2004; 16: 45-77.92. Ware JE Jr, Sherbourne CD. The MOS 36-item shortform health survey (SF-36). Conceptual frame-workand item selection. Med Care 1992; 30: 473-81.93. Hunt SM, McEven J, McKenna SP. Measuring healthstatus: a new tool for clinicians and epidemiologists. JRoy Coll Gen Pract 1985; 35: 185-8.94. Burckhardt CS, Clark SR, Bennett RM. The FibromyalgiaImpact Questionnaire: development andvalidation. J Rheumatol 1991; 18: 728-33.95. Sarzi-Puttini P, Atzeni F, Fiorini T, Panni B, RandisiG, Turiel M, et al. Validation of an Italian version ofthe Fibromyalgia Impact Questionnaire (FIQ-Q). ClinExp Rheumatol 2003; 21: 459-64.96. Simms RW, Felson DT, Goldenberg DL. Developmentof preliminary criteria for response to treatment in fibromyalgiasyndrome. J Rheumatol 1991; 18: 1558-63.97. Dunkl PR, Taylor AG, McConnell GG, Alfano AP,Conaway MR. Responsiveness of fibromyalgia clinicaltrial outcome measures. J Rheumatol 2000; 27:2683-91.
- Page 2 and 3: 2 P. Sarzi-Puttini et al.The meetin
- Page 4 and 5: 4 M. Cazzola et al.(2). In the earl
- Page 6 and 7: 6 M. Cazzola et al.enough to meet F
- Page 8 and 9: 8 M. Cazzola et al.Table I - Charac
- Page 10 and 11: 10 M. Cazzola et al.Table IV - Cond
- Page 12 and 13: 12 M. Cazzola et al.teria, three su
- Page 14 and 15: 14 M. Cazzola et al.tients with a n
- Page 16 and 17: 16 G. Cassisi et al.The cardinal fe
- Page 18 and 19: 18 G. Cassisi et al.StiffnessIn FM
- Page 20 and 21: 20 G. Cassisi et al.Autonomic and n
- Page 22 and 23: 22 G. Cassisi et al.Associated symp
- Page 24 and 25: 24 G. Cassisi et al.46. Coleman RM,
- Page 26 and 27: 26 S. Stisi et al.sensitization,”
- Page 28 and 29: 28 S. Stisi et al.Sum oflife-events
- Page 30 and 31: 30 S. Stisi et al.trols, they prese
- Page 32 and 33: 32 S. Stisi et al.stress, obtained,
- Page 34 and 35: 34 S. Stisi et al.50. Harris RE, Cl
- Page 36 and 37: ORIGINAL ARTICLEReumatismo, 2008; 6
- Page 38 and 39: 38 F. Atzeni et al.lalanine (17), a
- Page 40 and 41: 40 F. Atzeni et al.clearer and it m
- Page 42 and 43: 42 F. Atzeni et al.healthy control
- Page 44 and 45: 44 F. Atzeni et al.and/or verbal (e
- Page 46 and 47: 46 F. Atzeni et al.for study purpos
- Page 50 and 51: ORIGINAL ARTICLEReumatismo, 2008; 6
- Page 52 and 53: 52 P. Sarzi-Puttini et al.A larger
- Page 54 and 55: 54 P. Sarzi-Puttini et al.from 1966
- Page 56 and 57: 56 P. Sarzi-Puttini et al.rational,
- Page 58 and 59: 58 P. Sarzi-Puttini et al.49. Toffe
- Page 60 and 61: 60 R. Casale et al.cal exercise and
- Page 62 and 63: 62 R. Casale et al.definition of
- Page 64 and 65: 64 R. Casale et al.are more or less
- Page 66 and 67: 66 R. Casale et al.trol associated
- Page 68 and 69: 68 R. Casale et al.32. Lewit K. The
- Page 70 and 71: ORIGINAL ARTICLEReumatismo, 2008; 6
- Page 72 and 73: 72 L. Altomonte et al.In a clinical
- Page 74 and 75: 74 L. Altomonte et al.Table II - We
- Page 76 and 77: 76 L. Altomonte et al.treatments de
Change language